Results from a recent study reveal insured Americans believe health insurance is not living up to providing affordable and accessible healthcare.
In the fourth installment of the Patient Experience Survey (PES) from PhRMA/Ipsos, it was found coverage and affordability continue to fall short for many insured Americans who need access to care.
Conducted April 4 to 17 this year by Ipsos using the probability-based KnowledgePanel®, the survey is based on 5,152 adults aged 18 or older. The survey included 3,443 insured respondents who reported taking prescription medicines and 4,823 respondents who reported being insured.
Researchers designed the survey to explore the experiences and barriers patients face in accessing healthcare and prescription medicines.
Results reveal insured Americans believe health insurance is not living up to providing affordable and accessible healthcare. For example, many insured Americans worry insurance may not cover a medicine their doctor prescribes, and some report difficulty accessing medication because of insurance barriers. Out-of-pocket healthcare costs are also a significant concern for the insured.
Those in this category said they are more worried about their ability to afford their healthcare out-of-pocket costs (57%) than they are about expenses like the costs of healthy food (45%) or transportation (40%).
Other key findings in the survey include:
Data found participants believe potential solutions to combat these concerns can address out-of-pocket costs and insurance barriers.
Some of these solutions include ensuring more predictability in healthcare, so folks know how much they will pay for things such as prescription drugs every month.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen